Dimensional Fund Advisors’s Spero Therapeutics SPRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-10,003
| Closed | -$10.3K | – | 3353 |
|
2024
Q4 | $10.3K | Hold |
10,003
| – | – | ﹤0.01% | 3334 |
|
2024
Q3 | $13.4K | Hold |
10,003
| – | – | ﹤0.01% | 3342 |
|
2024
Q2 | $13K | Hold |
10,003
| – | – | ﹤0.01% | 3361 |
|
2024
Q1 | $17.2K | Hold |
10,003
| – | – | ﹤0.01% | 3372 |
|
2023
Q4 | $14.7K | Sell |
10,003
-1,750
| -15% | -$2.57K | ﹤0.01% | 3399 |
|
2023
Q3 | $14.2K | Hold |
11,753
| – | – | ﹤0.01% | 3452 |
|
2023
Q2 | $17K | Hold |
11,753
| – | – | ﹤0.01% | 3455 |
|
2023
Q1 | $17K | Hold |
11,753
| – | – | ﹤0.01% | 3443 |
|
2022
Q4 | $20 | Buy |
11,753
+1,750
| +17% | +$3 | ﹤0.01% | 3460 |
|
2022
Q3 | $20K | Sell |
10,003
-274,953
| -96% | -$550K | ﹤0.01% | 3463 |
|
2022
Q2 | $212K | Sell |
284,956
-121,990
| -30% | -$90.8K | ﹤0.01% | 3243 |
|
2022
Q1 | $3.54M | Buy |
406,946
+35,724
| +10% | +$311K | ﹤0.01% | 2641 |
|
2021
Q4 | $5.94M | Buy |
371,222
+41,589
| +13% | +$666K | ﹤0.01% | 2509 |
|
2021
Q3 | $6.07M | Sell |
329,633
-44,810
| -12% | -$825K | ﹤0.01% | 2523 |
|
2021
Q2 | $5.23M | Buy |
374,443
+31,937
| +9% | +$446K | ﹤0.01% | 2595 |
|
2021
Q1 | $5.04M | Buy |
342,506
+92,309
| +37% | +$1.36M | ﹤0.01% | 2581 |
|
2020
Q4 | $4.85M | Buy |
250,197
+19,188
| +8% | +$372K | ﹤0.01% | 2541 |
|
2020
Q3 | $2.58M | Buy |
231,009
+16,854
| +8% | +$188K | ﹤0.01% | 2671 |
|
2020
Q2 | $2.9M | Buy |
214,155
+15,294
| +8% | +$207K | ﹤0.01% | 2633 |
|
2020
Q1 | $1.61M | Buy |
198,861
+43,381
| +28% | +$351K | ﹤0.01% | 2779 |
|
2019
Q4 | $1.5M | Buy |
155,480
+32,475
| +26% | +$312K | ﹤0.01% | 2929 |
|
2019
Q3 | $1.3M | Buy |
123,005
+16,602
| +16% | +$176K | ﹤0.01% | 2953 |
|
2019
Q2 | $1.22M | Buy |
106,403
+88,534
| +495% | +$1.02M | ﹤0.01% | 3011 |
|
2019
Q1 | $229K | Buy |
+17,869
| New | +$229K | ﹤0.01% | 3287 |
|